American Century Companies’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.22M | Sell |
13,641
-8,232
| -38% | -$3.8M | ﹤0.01% | 1716 |
|
|
2026
Q1 | $10.5M | Sell |
21,873
-8,777
| -29% | -$4.49M | 0.01% | 1456 |
|
|
2025
Q4 | $17.2M | Buy |
30,650
+1,280
| +4% | +$727K | 0.01% | 1237 |
|
|
2025
Q3 | $15.1M | Buy |
29,370
+16,653
| +131% | +$7.27M | 0.01% | 1258 |
|
|
2025
Q2 | $3.99M | Buy |
12,717
+1,529
| +14% | +$459K | ﹤0.01% | 1757 |
|
|
2025
Q1 | $3.41M | Sell |
11,188
-2,979
| -21% | -$1M | ﹤0.01% | 1762 |
|
|
2024
Q4 | $4.71M | Sell |
14,167
-17,211
| -55% | -$5.84M | ﹤0.01% | 1631 |
|
|
2024
Q3 | $10.5M | Sell |
31,378
-15,655
| -33% | -$5.95M | 0.01% | 1294 |
|
|
2024
Q2 | $19.4M | Buy |
47,033
+11,299
| +32% | +$4.47M | 0.01% | 973 |
|
|
2024
Q1 | $14.4M | Sell |
35,734
-5,560
| -13% | -$1.95M | 0.01% | 1057 |
|
|
2023
Q4 | $12.7M | Sell |
41,294
-11,464
| -22% | -$3.09M | 0.01% | 1054 |
|
|
2023
Q3 | $12.8M | Buy |
52,758
+13,806
| +35% | +$3.53M | 0.01% | 980 |
|
|
2023
Q2 | $9.36M | Buy |
38,952
+29,726
| +322% | +$6.17M | 0.01% | 1078 |
|
|
2023
Q1 | $1.69M | Buy |
9,226
+1,977
| +27% | +$409K | ﹤0.01% | 1673 |
|
|
2022
Q4 | $1.54M | Buy |
7,249
+2,137
| +42% | +$427K | ﹤0.01% | 1648 |
|
|
2022
Q3 | $803K | Buy |
5,112
+1,536
| +43% | +$245K | ﹤0.01% | 1777 |
|
|
2022
Q2 | $535K | Sell |
3,576
-473
| -12% | -$68.5K | ﹤0.01% | 1898 |
|
|
2022
Q1 | $662K | Sell |
4,049
-2,564
| -39% | -$423K | ﹤0.01% | 1835 |
|
|
2021
Q4 | $1.44M | Sell |
6,613
-270
| -4% | -$56.5K | ﹤0.01% | 1493 |
|
|
2021
Q3 | $1.3M | Buy |
6,883
+121
| +2% | +$22.1K | ﹤0.01% | 1486 |
|
|
2021
Q2 | $1.19M | Hold |
6,762
| – | – | ﹤0.01% | 1469 |
|
|
2021
Q1 | $1.11M | Buy |
6,762
+3,545
| +110% | +$542K | ﹤0.01% | 1379 |
|
|
2020
Q4 | $448K | Sell |
3,217
-1,329
| -29% | -$168K | ﹤0.01% | 1599 |
|
|
2020
Q3 | $508K | Sell |
4,546
-388
| -8% | -$44.9K | ﹤0.01% | 1339 |
|
|
2020
Q2 | $459K | Sell |
4,934
-12,124
| -71% | -$1.03M | ﹤0.01% | 1306 |
|
|
2020
Q1 | $1.25M | Sell |
17,058
-7,209
| -30% | -$626K | ﹤0.01% | 945 |
|
|
2019
Q4 | $2.04M | Sell |
24,267
-62,467
| -72% | -$4.83M | ﹤0.01% | 934 |
|
|
2019
Q3 | $7.29M | Sell |
86,734
-45,648
| -34% | -$3.45M | 0.01% | 688 |
|
|
2019
Q2 | $8.66M | Sell |
132,382
-10,577
| -7% | -$610K | 0.01% | 660 |
|
|
2019
Q1 | $8.43M | Buy |
142,959
+1,519
| +1% | +$90.7K | 0.01% | 661 |
|
|
2018
Q4 | $7.49M | Buy |
141,440
+13,790
| +11% | +$757K | 0.01% | 675 |
|
|
2018
Q3 | $7.65M | Sell |
127,650
-42,142
| -25% | -$2.31M | 0.01% | 737 |
|
|
2018
Q2 | $7.3M | Buy |
169,792
+40,789
| +32% | +$1.65M | 0.01% | 745 |
|
|
2018
Q1 | $4.5M | Buy |
129,003
+116,740
| +952% | +$4.26M | ﹤0.01% | 857 |
|
|
2017
Q4 | $445K | Hold |
12,263
| – | – | ﹤0.01% | 1200 |
|
|
2017
Q3 | $391K | Buy |
+12,263
| New | +$375K | ﹤0.01% | 1249 |
|
Other funds holding MEDP
WA
American Century Companies's MEDP Position: Q2 2026 in Review
American Century Companies reduced its Medpace (MEDP) stake by 38% in Q2 2026, selling an estimated $3.8M and leaving 13,641 shares worth $7.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.
American Century Companies first reported a position in MEDP in Q3 2017 and has held it in 36 quarters since. The position peaked at $19.4M in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- American Century Companies held 13,641 shares of Medpace worth $7.22M as of Q2 2026.
- American Century Companies sold 8,232 Medpace shares in Q2 2026, an estimated $3.8M.
- Medpace made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1716 holding.
- American Century Companies first reported a position in Medpace in Q3 2017 and has held it in 36 quarters since.
- American Century Companies's Medpace position peaked at $19.4M in Q2 2024.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.